Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day. Subscribe for FREE Patients exploring weight-loss management strategies may elect ...

Sheu and colleagues additionally found that patients in the semaglutide group exhibited similar median HbA1c levels as controls before surgery (5.8% vs. 6%) and 1 year after surgery (5.5% vs.

Patients receiving preoperative semaglutide versus controls had similar median hemoglobin A1c levels before MBS and one year ...

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.

before taking semaglutide, using data collected between Oct. 1, 2019, and Dec. 31, 2023. A semaglutide group of 174,584 patients (51.8% women, 41.1% men) was compared with a control group of ...